Literature DB >> 29796651

Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

D A Eichenauer1, B M P Aleman2, M André3,4, M Federico5, M Hutchings6, T Illidge7,8, A Engert1, M Ladetto9.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29796651     DOI: 10.1093/annonc/mdy080

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  47 in total

1.  Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma.

Authors:  Alex Reza Gholiha; Peter Hollander; Ingrid Glimelius; Gustaf Hedstrom; Daniel Molin; Henrik Hjalgrim; Karin E Smedby; Jamileh Hashemi; Rose-Marie Amini; Gunilla Enblad
Journal:  Blood Adv       Date:  2021-03-23

2.  Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.

Authors:  Paul J Bröckelmann; Helen Goergen; Ulrich Keller; Julia Meissner; Rainer Ordemann; Teresa V Halbsguth; Stephanie Sasse; Martin Sökler; Andrea Kerkhoff; Stephan Mathas; Andreas Hüttmann; Matthias Bormann; Andreas Zimmermann; Jasmin Mettler; Michael Fuchs; Bastian von Tresckow; Christian Baues; Andreas Rosenwald; Wolfram Klapper; Carsten Kobe; Peter Borchmann; Andreas Engert
Journal:  JAMA Oncol       Date:  2020-06-01       Impact factor: 31.777

3.  The potential for PET-guided revascularization of coronary artery disease.

Authors:  Matthieu Pelletier-Galarneau; Terrence D Ruddy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-04-02       Impact factor: 9.236

Review 4.  Cure at what (systemic) financial cost? Integrating novel therapies into first-line Hodgkin lymphoma treatment.

Authors:  Scott F Huntington
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

5.  Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach.

Authors:  Phoebe T M Cheng; Diego Villa; R Petter Tonseth; David W Scott; Alina S Gerrie; Ciara L Freeman; Tom Pickles; Andrea C Lo; Pedro Farinha; Jeffrey W Craig; Graham W Slack; Randy D Gascoyne; François Bénard; Don Wilson; Brian Skinnider; Joseph M Connors; Laurie H Sehn; Kerry J Savage
Journal:  Blood Adv       Date:  2021-09-28

6.  Imaging Study of Pseudo-CT Synthesized From Cone-Beam CT Based on 3D CycleGAN in Radiotherapy.

Authors:  Hongfei Sun; Rongbo Fan; Chunying Li; Zhengda Lu; Kai Xie; Xinye Ni; Jianhua Yang
Journal:  Front Oncol       Date:  2021-03-12       Impact factor: 6.244

7.  Utility of Routine Surveillance Laboratory Testing in Detecting Relapse in Patients With Classic Hodgkin Lymphoma in First Remission: Results From a Large Single-Institution Study.

Authors:  Ryan C Lynch; Vandana Sundaram; Manisha Desai; Solomon Henry; Douglas Wood; Sarah Daadi; Richard T Hoppe; Ranjana Advani
Journal:  JCO Oncol Pract       Date:  2020-05-05

8.  Research on obtaining pseudo CT images based on stacked generative adversarial network.

Authors:  Hongfei Sun; Zhengda Lu; Rongbo Fan; Wenjun Xiong; Kai Xie; Xinye Ni; Jianhua Yang
Journal:  Quant Imaging Med Surg       Date:  2021-05

9.  Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.

Authors:  Simone de Vries; Michael Schaapveld; Cécile P M Janus; Laurien A Daniëls; Eefke J Petersen; Richard W M van der Maazen; Josée M Zijlstra; Max Beijert; Marten R Nijziel; Karijn M S Verschueren; Leontien C M Kremer; Anna M van Eggermond; Pieternella J Lugtenburg; Augustinus D G Krol; Judith M Roesink; Wouter J Plattel; Dick Johan van Spronsen; Gustaaf W van Imhoff; Jan Paul de Boer; Berthe M P Aleman; Flora E van Leeuwen
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

Review 10.  Immunotherapy in the treatment of lymphoma.

Authors:  Lazar S Popovic; Gorana Matovina-Brko; Maja Popovic; Milica Popovic; Ana Cvetanovic; Ivan Nikolic; Biljana Kukic; Dragana Petrovic
Journal:  World J Stem Cells       Date:  2021-06-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.